Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and…
Desta S. Lissanu, Chirag M. Vyas, Carol S. Lim, et al
PCC
Pharmacologic Management of TBI
Rounds in the General Hospital

July 16, 2024

Cognitive complaints, including difficulties with attention, concentration, and memory, are common in patients post-TBI; however, many medications have been studied in the treatment of cognition after TBI. Read on…
Sofia E. Matta, Christina LaCroix, Kaloyan Tanev, et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette…
Carol S. Lim, Abigail L. Donovan, Chirag M. Vyas, et al
PCC
Neuropsychiatric Complications of Hypervitaminosis D
Rounds in the General Hospital

June 13, 2024

A 28-year-old man presented to the emergency department with severe agitation, insomnia, weakness, constipation, and muscle jerks after nonsuicidal overdosing of vitamin D.
James K. Rustad, Adam Z. Spitz, Brandon C. Wilson, et al
PCC
Impact of Disability on Medical Care
Rounds in the General Hospital

June 6, 2024

Given that many people have disabilities, physicians should develop skills that assess the level of disability, the functional consequence of illness, and the social and physical environments of patients…
Mirza Baig, Andrew S. Chun, Ashika Bains, et al
PCC
Management of Rumination and Obsessions in Primary Care
Rounds in the General Hospital

May 30, 2024

Difficult-to-control negative repetitive thoughts can manifest as ruminations or obsessions. Appropriate early identification and intervention can positively affect the course and prevent an episode of psychiatric illness.
Sharmin Ghaznavi, Charlotte Schiewe, Theodore A. Stern

Page 58

More PCC Articles

JCP
Original Research

September 8, 2020

This pilot study compared the effects of parent lisdexamfetamine to behavioral parent training on maternal ADHD, parenting, and child ADHD symptoms in families in which the mother had currently…
Andrea Chronis-Tuscano, William French, Jennifer Strickland, et al
JCP
DELETE eReport

September 8, 2020

Individuals with narcolepsy may experience not only academic, social, and occupational consequences but also dangerous driving or other accidents, meaning that effective treatment is critical. Here, review the evidence…
Thomas Roth
JCP
Review Article

September 1, 2020

When pregnant patients with a history of depression ask you about eating fish or using an omega-3 supplement, what do you tell them? Learn about research in the peripartum…
Roel J. T. Mocking, Katja Steijn, Carolien Roos, et al
JCP
Commentary

September 1, 2020

Read a commentary discussing the use of omega-3 fatty acids in the treatment of perinatal depression.
Jerome Sarris, Marlene P. Freeman
JCP
Brief Report

September 1, 2020

Read a study from Spain comparing the trends in suicide ideation and attempts after the arrival of COVID-19.
Daniel Hernández-Calle, Gonzalo Martínez-Alés, Roberto Mediavilla, et al
JCP
Commentary

August 25, 2020

In this commentary, the authors discuss the article by Bartels and colleagues on the relationship between antidepressant use and risk of incident dementia in older adults.
Eric E. Brown, Tarek K. Rajji, Benoit H. Mulsant
JCP
Original Research

August 25, 2020

This study evaluated the efficacy and tolerability of escitalopram in adolescents with generalized anxiety disorder as well as the impact of variants in genes and CYP2C19 phenotypes on response…
Jeffrey R. Strawn, Jeffrey A. Mills, Heidi Schroeder, et al
JCP
Original Research

August 25, 2020

The effects of antidepressants and treatment duration on the progression to dementia are currently unclear. This case-control study analyzed the effects of several antidepressants with different treatment durations on…
Claudia Bartels, Michael Belz, Jonathan Vogelgsang, et al
JCP
Original Research

August 18, 2020

Lithium is an important mood disorder treatment, but the renal risks in older adults are unclear. This population-based cohort study looked at risk of renal decline with lithium vs…
Soham Rej, Nathan Herrmann, Andrea Gruneir, et al
JCP
Original Research

August 18, 2020

Long-acting injectable (LAI) antipsychotics improve adherence, reduce treatment gaps, and improve clinical outcomes. This report describes the long-term safety, tolerability, and symptom trajectory with the LAI antipsychotic aripiprazole lauroxil.
John Lauriello, Amy Claxton, Yangchun Du, et al
JCP
Original Research

August 11, 2020

An antidepressant medication switch often follows a failed initial trial with SSRIs. This study sought to determine the probability and timing of both response and remission and the optimal…
A. John Rush, Charles South, Manish K. Jha, et al
JCP
Letter to the Editor

August 4, 2020

This letter, which comments on a recent article by Iltis et al, discusses exclusion of suicidal patients from clinical trials for depression.
Elizabeth D. Ballard, Lawrence T. Park, Maryland Pao

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe